$397 Million is the total value of Main Management ETF Advisors, LLC's 11 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 36.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XLK | Buy | Technology Select Sector SPDR Fund | $81,967,000 | +23.0% | 1,088,100 | +13.4% | 20.64% | +4.0% |
| XLV | Buy | Health Care Select Sector SPDR Fund | $63,712,000 | +29.3% | 669,600 | +13.4% | 16.04% | +9.3% |
| XLF | Buy | Financial Select Sector SPDR Fund | $57,711,000 | +17.6% | 2,092,500 | +13.4% | 14.53% | -0.5% |
| KBE | Buy | SPDR S&P Bank ETF | $40,278,000 | +12.0% | 864,900 | +13.4% | 10.14% | -5.3% |
| XME | Buy | SPDR S&P Metals & Mining ETF | $37,169,000 | +9.2% | 1,088,100 | +13.4% | 9.36% | -7.6% |
| IEMG | Buy | iShares Core MSCI Emerging Markets ETF | $24,559,000 | +11.8% | 474,300 | +13.4% | 6.18% | -5.4% |
| XBI | Buy | SPDR S&P Biotech ETF | $24,073,000 | +14.2% | 251,100 | +13.4% | 6.06% | -3.4% |
| IBB | Buy | iShares Nasdaq Biotechnology ETF | $20,413,000 | +25.9% | 167,400 | +13.4% | 5.14% | +6.5% |
| VOE | New | Vanguard Mid-Cap Value ETF | $18,928,000 | – | 167,400 | +100.0% | 4.76% | – |
| ASHR | New | Xtrackers Harvest CSI 300 China A-Shares ETF | $16,974,000 | – | 669,600 | +100.0% | 4.27% | – |
| IGV | Buy | iShares North American Tech-Software ETF | $11,437,000 | +27.2% | 55,800 | +13.4% | 2.88% | +7.6% |
| BIL | Exit | SPDR Bloomberg Barclays 1-3 Month T-Bill ETF | $0 | – | -172,200 | -100.0% | -4.70% | – |
| ITB | Exit | iShares U.S. Home Construction ETF | $0 | – | -442,800 | -100.0% | -5.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Technology Select Sector SPDR Fund | 24 | Q3 2023 | 23.4% |
| Health Care Select Sector SPDR Fund | 24 | Q3 2023 | 17.2% |
| Financial Select Sector SPDR Fund | 22 | Q1 2023 | 16.4% |
| SPDR S&P Biotech ETF | 22 | Q1 2023 | 6.3% |
| iShares Nasdaq Biotechnology ETF | 20 | Q3 2022 | 5.1% |
| VANECK VECTORS SEMICONDUCTOR ETF | 16 | Q3 2023 | 6.3% |
| Invesco QQQ Trust Series 1 | 15 | Q3 2023 | 10.9% |
| iShares U.S. Home Construction ETF | 15 | Q4 2021 | 9.8% |
| iShares MSCI USA Value Factor ETF | 12 | Q2 2022 | 8.2% |
| Schwab U.S. Large-Cap Value ETF | 12 | Q1 2023 | 6.1% |
View Main Management ETF Advisors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-15 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-10 |
| 13F-HR | 2022-02-15 |
View Main Management ETF Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.